Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks

BMC Systems Biology

Volumn 6, Issue , 2012, Pages

  Martin, Florian ^a   Thomson, Ty M ^c   Sewer, Alain ^a   Drubin, David A ^c   Mathis, Carole ^a   Weisensee, Dirk ^b   Pratt, Dexter ^c   Hoeng, Julia ^a   Peitsch, Manuel C ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Philip Morris Research Laboratories GmbH   (Germany)

^c Selventa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOLOGICAL MODEL; CELL CYCLE; HUMAN; METABOLISM; METHODOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

CELL CYCLE; HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861643512     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-54     Document Type: Article

References (37)

1. Reverse Causal Reasoning Methods Whitepaper. [http://www.selventa.com/technology/white-papers].
2. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003, 4:117. 10.1186/gb-2003-4-9-117, 193646, 12952525.
3. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002, 1:304-313. 10.1074/mcp.M200008-MCP200, 12096112.
4. Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, Chen X, Li L, Wu S, Chen Y, et al. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 2008, 40:426-436.
5. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752. 10.1038/35021093, 10963602.
6. Liu ET. Classification of cancers by expression profiling. Curr Opin Genet Dev 2003, 13:97-103. 10.1016/S0959-437X(03)00008-X, 12573442.
7. Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, Wunderlich H, Gajda MR, Junker K. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol 2011, 29:367-373. 10.1007/s00345-010-0633-4, 21229250.
8. Yan X, Ma L, Yi D, Yoon JG, Diercks A, Foltz G, Price ND, Hood LE, Tian Q. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A 2011, 108:1591-1596. 10.1073/pnas.1018696108, 3029739, 21220328.
9. Loboda A, Nebozhyn M, Cheng C, Vessey R, Huang P, Dai H, Watters JW. Biomarker discovery: identification of a growth factor gene signature. Clin Pharmacol Ther 2009, 86:92-96. 10.1038/clpt.2009.48, 19387436.
10. Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet 2009, 5:e1000676. 10.1371/journal.pgen.1000676, 2748685, 19798449.
11. Chang JT, Carvalho C, Mori S, Bild AH, Gatza ML, Wang Q, Lucas JE, Potti A, Febbo PG, West M, Nevins JR. A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell 2009, 34:104-114. 10.1016/j.molcel.2009.02.030, 2694616, 19362539.
12. Laifenfeld D, Gilchrist A, Drubin D, Jorge M, Eddy SF, Frushour BP, Ladd B, Obert LA, Gosink MM, Cook JC, et al. The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. Toxicol Sci 2010, 113:254-266. 10.1093/toxsci/kfp213, 2794330, 19812364.
13. Smith JJ, Kenney RD, Gagne DJ, Frushour BP, Ladd W, Galonek HL, Israelian K, Song J, Razvadauskaite G, Lynch AV, et al. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst Biol 2009, 3:31. 10.1186/1752-0509-3-31, 2660283, 19284563.
14. Kumar R, Blakemore SJ, Ellis CE, Petricoin EF, Pratt D, Macoritto M, Matthews AL, Loureiro JJ, Elliston K. Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693. BMC Genomics 2010, 11:419. 10.1186/1471-2164-11-419, 2996947, 20604938.
15. Berkofsky-Fessler W, Nguyen TQ, Delmar P, Molnos J, Kanwal C, DePinto W, Rosinski J, McLoughlin P, Ritland S, DeMario M, et al. Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients. Mol Cancer Ther 2009, 8:2517-2525. 10.1158/1535-7163.MCT-09-0083, 19755512.
16. Westra JW, Schlage WK, Frushour BP, Gebel S, Catlett NL, Han W, Eddy SF, Hengstermann A, Matthews AL, Mathis C, et al. Construction of a Computable Cell Proliferation Network Focused on Non-Diseased Lung Cells. BMC Syst Biol 2011, 5:105. 10.1186/1752-0509-5-105, 3160372, 21722388.
17. Schlage WK, Westra JW, Gebel S, Catlett NL, Mathis C, Frushour BP, Hengstermann A, Van Hooser A, Poussin C, Wong B, et al. A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue. BMC Syst Biol 2011, 5:168. 10.1186/1752-0509-5-168, 3224482, 22011616.
18. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004, 306:704-708. 10.1126/science.1099962, 15499023.
19. Tay S, Hughey JJ, Lee TK, Lipniacki T, Quake SR, Covert MW. Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature 2010, 466:267-271. 10.1038/nature09145, 3105528, 20581820.
20. Thierry S, Marechal V, Rosenzwajg M, Sabbah M, Redeuilh G, Nicolas JC, Gozlan J. Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter. J Virol 2004, 78:12198-12206. 10.1128/JVI.78.22.12198-12206.2004, 525107, 15507606.
21. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273. 10.1038/ng1180, 12808457.
22. Saxena V, Orgill D, Kohane I. Absolute enrichment: gene set enrichment analysis for homeostatic systems. Nucleic Acids Res 2006, 34:e151. 10.1093/nar/gkl766, 1702493, 17130162.
23. Geistlinger L, Csaba G, Kuffner R, Mulder N, Zimmer R. From sets to graphs: towards a realistic enrichment analysis of transcriptomic systems. Bioinformatics 2011, 27:i366-373. 10.1093/bioinformatics/btr228, 3117393, 21685094.
24. Liao JC, Boscolo R, Yang YL, Tran LM, Sabatti C, Roychowdhury VP. Network component analysis: reconstruction of regulatory signals in biological systems. Proc Natl Acad Sci U S A 2003, 100:15522-15527. 10.1073/pnas.2136632100, 307600, 14673099.
25. Kao KC, Yang YL, Boscolo R, Sabatti C, Roychowdhury V, Liao JC. Transcriptome-based determination of multiple transcription regulator activities in Escherichia coli by using network component analysis. Proc Natl Acad Sci U S A 2004, 101:641-646. 10.1073/pnas.0305287101, 327201, 14694202.
26. R Development Core Team. R: A Language and Environment for Statistical Computing 2009,
27. Gentleman R. Bioinformatics and computational biology solutions using R and Bioconductor 2005, Springer Science + Business Media, New York.
28. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
29. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.
30. Veiga DF, Dutta B, Balazsi G. Network inference and network response identification: moving genome-scale data to the next level of biological discovery. Molecular bioSystems 2010, 6:469-480. 10.1039/b916989j, 3087299, 20174676.
31. Strimmer K. A unified approach to false discovery rate estimation. BMC Bioinformatics 2008, 9:303. 10.1186/1471-2105-9-303, 2475539, 18613966.
32. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001, 98:31-36. 10.1073/pnas.98.1.31, 14539, 11134512.
33. Satterthwaite FE. An approximate distribution of estimates of variance components. Biometrics 1946, 2:110-114. 10.2307/3002019, 20287815.
34. Welch BL. The generalisation of student's problems when several different population variances are involved. Biometrika 1947, 34:28-35.
35. Efron B. The jackknife, the bootstrap, and other resampling plans 1982, Society for Industrial and Applied Mathematics, Philadelphia.
36. Diciccio TJ, Romano JP. A review of bootstrap confidence intervals. J R Stat Soc 1988, 50:338-354.
37. The ArrayExpress Archive. [http://www.ebi.ac.uk/arrayexpress/].